Endonovo Therapeutics, Inc. (ENDV)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 15, 2026, 12:46 PM EST
Endonovo Therapeutics Market Cap
Endonovo Therapeutics has a market cap or net worth of $180.76 thousand as of April 15, 2026. Its market cap has decreased by -48.56% in one year.
Market Cap
180.76K
Enterprise Value
n/a
Revenue
255.72K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 20, 2013, Endonovo Therapeutics's market cap has increased from 78.90K to 180.76K, an increase of 129.10%. That is a compound annual growth rate of 6.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 1.81K | -99.00% |
| Dec 31, 2025 | 180.76K | -16.91% |
| Dec 31, 2024 | 217.55K | -92.16% |
| Dec 29, 2023 | 2.77M | -20.72% |
| Dec 30, 2022 | 3.50M | 211.37% |
| Dec 31, 2021 | 1.12M | 127.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rebus Holdings | 3.21K |
| Innoveren Scientific | 3.20K |
| Comera Life Sciences Holdings | 3.07K |
| OncoVista Innovative Therapies | 2.36K |
| Evelo Biosciences | 1.90K |
| Affimed | 1.64K |
| ZIM Corporation | 1.63K |
| DNAPrint Genomics | 1.30K |